Overview

A class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) and certain of the Company’s former and current senior executive officers alleging violations of the federal securities laws.  The Walgreens class action lawsuit is brought on behalf of all persons and entities who purchased or otherwise acquired Walgreens securities between October 12, 2023, to June 26, 2024, both dates inclusive (the “Class Period”).  Investors have until September 10, 2024, to seek appointment as lead plaintiff of the Walgreens class action lawsuit.

Walgreens is a global company that delivers retail and pharmacy, and healthcare services across the United States, Europe, and Latin America.  The Company also has a healthcare segment dedicated solely to the United States.  Walgreens splits itself into three segments: United States retail and pharmacy, international sales, and United States healthcare

The Walgreens class action lawsuit alleges that Defendants provided investors with material information concerning Walgreens’ expected revenue for fiscal year 2024.  Defendants’ statements included, among other things, confidence in the Company’s pharmacy division brand inflation, volume growth, cost execution, discipline, and overall contribution to the Company.

Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminated materially false and misleading statements and/or concealing material adverse facts concerning the true state of Walgreens’ pharmacy division; notably, that it was not truly equipped to handle the ongoing challenges in its industry and that Walgreens would require significant restructuring to create a sustainable model.  As a result of such statements, these material facts caused Plaintiff and other shareholders to purchase Walgreens’ securities at artificially inflated prices, and when the truth emerged, the Company suffered a precipitous decline in the market value of its securities, and class members suffered significant losses and damages.

*          *          *

If you purchased or otherwise acquired Walgreens securities between October 12, 2023, to June 26, 2024, both dates inclusive, and you wish to serve as lead plaintiff in this lawsuit, we encourage you to submit your information to DiCello Levitt LLP via the form on this page. 

You can also contact DiCello Levitt partner Brian O’Mara by calling (888) 287-9005 or at [email protected]. 

The deadline to apply to the Court to serve as a lead plaintiff in the Walgreens lawsuit is September 10, 2024.